322 related articles for article (PubMed ID: 21045207)
21. Fibroblast growth factor signaling in Caenorhabditis elegans.
Borland CZ; Schutzman JL; Stern MJ
Bioessays; 2001 Dec; 23(12):1120-30. PubMed ID: 11746231
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor signaling controlling osteoblast differentiation.
Marie PJ
Gene; 2003 Oct; 316():23-32. PubMed ID: 14563548
[TBL] [Abstract][Full Text] [Related]
23. Roles of FGF signaling in skeletal development and human genetic diseases.
Chen L; Deng CX
Front Biosci; 2005 May; 10():1961-76. PubMed ID: 15769677
[TBL] [Abstract][Full Text] [Related]
24. Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.
Chaffer CL; Dopheide B; Savagner P; Thompson EW; Williams ED
Differentiation; 2007 Nov; 75(9):831-42. PubMed ID: 17697126
[TBL] [Abstract][Full Text] [Related]
25. Thyroid hormones regulate fibroblast growth factor receptor signaling during chondrogenesis.
Barnard JC; Williams AJ; Rabier B; Chassande O; Samarut J; Cheng SY; Bassett JH; Williams GR
Endocrinology; 2005 Dec; 146(12):5568-80. PubMed ID: 16150908
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor receptor signaling in kidney and lower urinary tract development.
Walker KA; Sims-Lucas S; Bates CM
Pediatr Nephrol; 2016 Jun; 31(6):885-95. PubMed ID: 26293980
[TBL] [Abstract][Full Text] [Related]
27. FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod.
Hung IH; Yu K; Lavine KJ; Ornitz DM
Dev Biol; 2007 Jul; 307(2):300-13. PubMed ID: 17544391
[TBL] [Abstract][Full Text] [Related]
28. Cellular signaling by fibroblast growth factor receptors.
Eswarakumar VP; Lax I; Schlessinger J
Cytokine Growth Factor Rev; 2005 Apr; 16(2):139-49. PubMed ID: 15863030
[TBL] [Abstract][Full Text] [Related]
29. Altered FGF signalling in congenital craniofacial and skeletal disorders.
Moosa S; Wollnik B
Semin Cell Dev Biol; 2016 May; 53():115-25. PubMed ID: 26686047
[TBL] [Abstract][Full Text] [Related]
30. FGF receptor mutations: dimerization syndromes, cell growth suppression, and animal models.
Kannan K; Givol D
IUBMB Life; 2000 Mar; 49(3):197-205. PubMed ID: 10868910
[TBL] [Abstract][Full Text] [Related]
31. The roles of the FGF signal in zebrafish embryos analyzed using constitutive activation and dominant-negative suppression of different FGF receptors.
Ota S; Tonou-Fujimori N; Yamasu K
Mech Dev; 2009; 126(1-2):1-17. PubMed ID: 19015027
[TBL] [Abstract][Full Text] [Related]
32. FGF-FGFR signaling in vertebrate organogenesis.
Kato S; Sekine K
Cell Mol Biol (Noisy-le-grand); 1999 Jul; 45(5):631-8. PubMed ID: 10512194
[TBL] [Abstract][Full Text] [Related]
33. From genotype to phenotype: the differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes.
Britto JA; Evans RD; Hayward RD; Jones BM
Plast Reconstr Surg; 2001 Dec; 108(7):2026-39; discussion 2040-6. PubMed ID: 11743396
[TBL] [Abstract][Full Text] [Related]
34. ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3.
Balek L; Gudernova I; Vesela I; Hampl M; Oralova V; Kunova Bosakova M; Varecha M; Nemec P; Hall T; Abbadessa G; Hatch N; Buchtova M; Krejci P
Bone; 2017 Dec; 105():57-66. PubMed ID: 28826843
[TBL] [Abstract][Full Text] [Related]
35. Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle.
Sogos V; Balaci L; Ennas MG; Dell'era P; Presta M; Gremo F
Dev Dyn; 1998 Apr; 211(4):362-73. PubMed ID: 9566955
[TBL] [Abstract][Full Text] [Related]
36. FGFs, their receptors, and human limb malformations: clinical and molecular correlations.
Wilkie AO; Patey SJ; Kan SH; van den Ouweland AM; Hamel BC
Am J Med Genet; 2002 Oct; 112(3):266-78. PubMed ID: 12357470
[TBL] [Abstract][Full Text] [Related]
37. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.
Lomri A; Lemonnier J; Hott M; de Parseval N; Lajeunie E; Munnich A; Renier D; Marie PJ
J Clin Invest; 1998 Mar; 101(6):1310-7. PubMed ID: 9502772
[TBL] [Abstract][Full Text] [Related]
38. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.
Carter EP; Fearon AE; Grose RP
Trends Cell Biol; 2015 Apr; 25(4):221-33. PubMed ID: 25467007
[TBL] [Abstract][Full Text] [Related]
39. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract][Full Text] [Related]
40. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer.
Brooks AN; Kilgour E; Smith PD
Clin Cancer Res; 2012 Apr; 18(7):1855-62. PubMed ID: 22388515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
